Patent classifications
A61F2/12
PROSTHETIC IMPLANTS HAVING SHELLS WITH FLEXIBLE NEEDLE STOP PATCHES MADE OF TWO OR MORE LAYERS OF TEXTILE MATERIAL
A prosthetic implant, such as a tissue expander, includes a silicone shell having an anterior wall and a posterior wall, and a needle stop patch secured over an inner surface of the posterior wall of the silicone shell. The needle stop patch has two or more layers of a textile material that are stacked atop one another. The textile material is flexible and includes woven threads or fiber. A bonding material bonds together the two or more layers of the textile material that are stacked atop one another. The outer edges of the respective layers are feathered for minimizing step effects between adjacent ones of the layers. A self-sealing membrane covers the anterior wall of the silicone shell. The dernier level of the textile layers increases between top and bottom layers for progressively increasing resistance tom a needle passing through the needle stop patch.
Packaging and delivery device for a breast implant
Packaging for a breast implant, the packaging comprising a lid and a cavity, wherein one of the lid or the cavity is configured to provide direct delivery of the breast implant from the packaging to a surgical pocket. A method for the direct delivery of a breast implant from breast implant packaging to a surgical pocket, the method comprising the steps of: a. ensuring that a delivery device present in a lid or a cavity of the packaging is in a delivery position; b. forming an aperture in the delivery device, thereby opening the packaging; c. transferring the breast implant to the delivery device; d. positioning the delivery device in contact with the surgical pocket; and e. delivering the breast implant to the surgical pocket.
Packaging and delivery device for a breast implant
Packaging for a breast implant, the packaging comprising a lid and a cavity, wherein one of the lid or the cavity is configured to provide direct delivery of the breast implant from the packaging to a surgical pocket. A method for the direct delivery of a breast implant from breast implant packaging to a surgical pocket, the method comprising the steps of: a. ensuring that a delivery device present in a lid or a cavity of the packaging is in a delivery position; b. forming an aperture in the delivery device, thereby opening the packaging; c. transferring the breast implant to the delivery device; d. positioning the delivery device in contact with the surgical pocket; and e. delivering the breast implant to the surgical pocket.
Lighter weight implant
A breast implant is provided which includes a filling, or core having a lower overall density relative to silicone gel-filled or saline-filled implant. The core may be a composite including flexible bodies, for example, air-containing or gas-containing bodies, and a gel medium between or around the bodies.
Lighter weight implant
A breast implant is provided which includes a filling, or core having a lower overall density relative to silicone gel-filled or saline-filled implant. The core may be a composite including flexible bodies, for example, air-containing or gas-containing bodies, and a gel medium between or around the bodies.
Adjustable implant
The present disclosure describes various embodiments of adjustable implants, particularly permanent breast implants, intended for implantation into a subject, particularly a human subject. In some embodiments, the adjustable implant comprises a shell including a resilient shell membrane, a first reservoir containing a fluid, e.g., a saline, a second reservoir including a resilient second-reservoir membrane, and a pump. The pump may include a first pump actuator, a first pump inlet, and a first pump outlet. The first reservoir and second reservoir may be disposed within the shell and be in fluid communication via the pump. Fluid may be transferred between the two reservoirs to change the profile of the implant.
Adjustable implant
The present disclosure describes various embodiments of adjustable implants, particularly permanent breast implants, intended for implantation into a subject, particularly a human subject. In some embodiments, the adjustable implant comprises a shell including a resilient shell membrane, a first reservoir containing a fluid, e.g., a saline, a second reservoir including a resilient second-reservoir membrane, and a pump. The pump may include a first pump actuator, a first pump inlet, and a first pump outlet. The first reservoir and second reservoir may be disposed within the shell and be in fluid communication via the pump. Fluid may be transferred between the two reservoirs to change the profile of the implant.
Plasma treating an implant
A method is provided for treating an implant in a medical care center prior to using the implant in a medical procedure. The method comprises applying a plasma-generating electromagnetic (EM) field using at least one electrode so as to generate plasma in a vicinity of the implant while displacing the electrode and the implant relative to one another. A portable plasma module and a docking station configured to connect to the portable plasma module, thereby forming a plasma generating system, are also provided. A plasma generating apparatus for treating an implant prior to using the implant in a medical procedure is also provided.
AN IMPLANTABLE MEDICAL DEVICE
An implantable medical device having a soft tissue interfacing surface comprises at least one soft actuatable capsule having a soft tissue interfacing deflectable membrane configured for cyclical deflection upon actuation of the capsule to modulate the biomechanics of the soft tissue interface during use. The actuatable capsule may comprise an actuation chamber containing a first fluid, a therapeutic chamber containing a second fluid, a deflectable membrane separating the actuation chamber and therapeutic chamber, and an actuation conduit in fluidic communication with the actuation chamber for pneumatic actuation of the actuation chamber. The therapeutic chamber comprises the soft tissue interfacing deflectable membrane which is configured to cyclically deflect during actuation of the capsule and modulate the biomechanics of the soft tissue interface by altering one or more of strain, fluid flow and cellular activity in peri-implant tissue at the soft tissue interface. Methods of reducing fibrotic encapsulation of an implantable medical device are also described.
IMPLANT DELIVERY SLEEVES HAVING NON-TAPERED TUBULAR WALLS WITH CONSTRICTED IMPLANT DELIVERY CHANNELS FOR INSERTING IMPLANTS INTO TISSUE POCKETS
An implant delivery sleeve comprises a tubular wall having a proximal end with a proximal opening, a distal end with a distal opening, and an implant delivery channel extending between the proximal and distal ends of said tubular wall. A plurality of bands interconnect portions of the tubular wall for constricting the implant delivery channel adjacent the distal end of the tubular wall. As an implant is advanced toward the distal end of the tubular wall, the constriction squeezes and/or deforms the implant for facilitating insertion into an incision that is smaller than the normal size of the implant.